Chang-Wook Lee - Publications

Affiliations: 
2005-2011 Scripps Research Institute, La Jolla, La Jolla, CA, United States 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Herr DR, Reolo MJ, Peh YX, Wang W, Lee CW, Rivera R, Paterson IC, Chun J. Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy. Scientific Reports. 6: 24541. PMID 27080739 DOI: 10.1038/Srep24541  0.755
2013 Herr DR, Lee CW, Wang W, Ware A, Rivera R, Chun J. Sphingosine 1-phosphate receptors are essential mediators of eyelid closure during embryonic development. The Journal of Biological Chemistry. 288: 29882-9. PMID 24003216 DOI: 10.1074/jbc.M113.510099  0.776
2011 Herr KJ, Herr DR, Lee CW, Noguchi K, Chun J. Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling. Proceedings of the National Academy of Sciences of the United States of America. 108: 15444-9. PMID 21878565 DOI: 10.1073/Pnas.1106129108  0.783
2011 Choi JW, Gardell SE, Herr DR, Rivera R, Lee CW, Noguchi K, Teo ST, Yung YC, Lu M, Kennedy G, Chun J. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proceedings of the National Academy of Sciences of the United States of America. 108: 751-6. PMID 21177428 DOI: 10.1073/Pnas.1014154108  0.629
2010 Lee CW, Choi JW, Chun J. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis. Archives of Pharmacal Research. 33: 1567-74. PMID 21052934 DOI: 10.1007/S12272-010-1008-5  0.7
2010 Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J. LPA receptors: subtypes and biological actions. Annual Review of Pharmacology and Toxicology. 50: 157-86. PMID 20055701 DOI: 10.1146/Annurev.Pharmtox.010909.105753  0.584
2009 Sun Y, Lee JH, Kim NH, Lee CW, Kim MJ, Kim SH, Huh SO. Lysophosphatidylcholine-induced apoptosis in H19-7 hippocampal progenitor cells is enhanced by the upregulation of Fas Ligand. Biochimica Et Biophysica Acta. 1791: 61-8. PMID 19007912 DOI: 10.1016/J.Bbalip.2008.09.007  0.307
2008 Choi JW, Lee CW, Chun J. Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. Biochimica Et Biophysica Acta. 1781: 531-9. PMID 18407842 DOI: 10.1016/J.Bbalip.2008.03.004  0.738
2008 Lee CW, Kim NH, Choi HK, Sun Y, Nam JS, Rhee HJ, Chun J, Huh SO. Lysophosphatidic acid-induced c-fos up-regulation involves cyclic AMP response element-binding protein activated by mitogen- and stress-activated protein kinase-1. Journal of Cellular Biochemistry. 104: 785-94. PMID 18172855 DOI: 10.1002/Jcb.21663  0.549
2007 Lee CW, Rivera R, Dubin AE, Chun J. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation. The Journal of Biological Chemistry. 282: 4310-7. PMID 17166850 DOI: 10.1074/Jbc.M610826200  0.797
2006 Lee CW, Rivera R, Gardell S, Dubin AE, Chun J. GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. The Journal of Biological Chemistry. 281: 23589-97. PMID 16774927 DOI: 10.1074/Jbc.M603670200  0.773
2003 Lee CW, Nam JS, Park YK, Choi HK, Lee JH, Kim NH, Cho J, Song DK, Suh HW, Lee J, Kim YH, Huh SO. Lysophosphatidic acid stimulates CREB through mitogen- and stress-activated protein kinase-1. Biochemical and Biophysical Research Communications. 305: 455-61. PMID 12763014 DOI: 10.1016/S0006-291X(03)00790-3  0.348
Show low-probability matches.